URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Deepak Sahasrabudhe

Concepts (217)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Antigens, Neoplasm
5
1987
109
0.890
Why?
Polymorphism, Single Nucleotide
2
2010
90
0.750
Why?
Tissue Kallikreins
1
2010
11
0.730
Why?
Prostatic Neoplasms
3
2008
540
0.650
Why?
T-Lymphocytes, Cytotoxic
2
2001
147
0.550
Why?
HLA Antigens
1
2006
98
0.550
Why?
Receptors, Antigen, T-Cell
1
2006
68
0.550
Why?
Leukemia, Myeloid
1
2006
121
0.530
Why?
Colonic Neoplasms
2
1999
123
0.510
Why?
Antigens, Differentiation, Myelomonocytic
1
2003
26
0.450
Why?
Immune Tolerance
4
1986
150
0.450
Why?
Receptor, Epidermal Growth Factor
1
2003
96
0.420
Why?
Vascular Endothelial Growth Factor A
1
2003
212
0.400
Why?
Antigens, CD
1
2003
254
0.390
Why?
Organ Transplantation
1
2000
11
0.390
Why?
Lymphoproliferative Disorders
1
2000
30
0.380
Why?
Antigens, CD20
1
2000
27
0.380
Why?
T-Lymphocytes, Regulatory
3
1987
51
0.350
Why?
Sarcoma
2
2008
64
0.340
Why?
T-Lymphocytes
4
1986
564
0.330
Why?
Carcinoma, Renal Cell
2
1986
56
0.320
Why?
Kidney Neoplasms
2
1986
104
0.310
Why?
Neoplasms, Second Primary
2
2008
125
0.280
Why?
Middle Aged
12
1981
10013
0.270
Why?
Prognosis
4
1981
1078
0.270
Why?
Immunotherapy, Active
2
1990
5
0.270
Why?
Aged
12
1981
7392
0.270
Why?
Interferon-beta
1
1994
63
0.240
Why?
Interferon-alpha
1
1994
85
0.240
Why?
Neoadjuvant Therapy
2
2008
32
0.240
Why?
Neoplasms, Experimental
1
1994
149
0.240
Why?
Hypersensitivity, Delayed
2
1986
52
0.230
Why?
Genetic Markers
2
2010
132
0.230
Why?
Lung Neoplasms
3
1992
435
0.220
Why?
Humans
22
1981
37165
0.220
Why?
Raynaud Disease
1
1992
7
0.220
Why?
Paraneoplastic Syndromes
1
1992
12
0.220
Why?
Spermatozoa
1
2012
35
0.210
Why?
Genotype
2
2010
473
0.210
Why?
Male
13
1981
20139
0.210
Why?
Deferoxamine
1
1991
17
0.200
Why?
Urinary Bladder Neoplasms
2
2005
172
0.200
Why?
Androgen Antagonists
1
2012
63
0.200
Why?
Deoxycytidine
1
2011
28
0.200
Why?
Cisplatin
1
2011
93
0.190
Why?
Aged, 80 and over
4
2005
2588
0.190
Why?
Radiosurgery
1
2011
73
0.180
Why?
Retrospective Studies
5
1990
2302
0.180
Why?
Alleles
1
2010
206
0.170
Why?
Disease-Free Survival
1
2010
204
0.170
Why?
Adult
8
1986
11572
0.170
Why?
Breast Neoplasms
2
2004
666
0.160
Why?
Soft Tissue Neoplasms
1
2008
46
0.160
Why?
Amino Acid Sequence
3
2001
1227
0.160
Why?
Recurrence
1
2010
697
0.150
Why?
Graft vs Host Disease
1
2008
95
0.150
Why?
Cimetidine
1
1987
9
0.150
Why?
Interferon Type I
1
1987
38
0.150
Why?
Mice, Inbred BALB C
4
1987
625
0.150
Why?
Female
12
1986
20222
0.150
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2011
436
0.150
Why?
Skin Diseases
1
2008
121
0.150
Why?
Bone Marrow Transplantation
1
2008
201
0.150
Why?
Leukemia, Myeloid, Acute
1
2008
183
0.140
Why?
Urologic Neoplasms
1
2005
10
0.130
Why?
Tumor Cells, Cultured
3
1993
886
0.130
Why?
Quinolones
1
2005
27
0.130
Why?
Acute Disease
2
1983
591
0.130
Why?
Dinitrofluorobenzene
3
1987
7
0.130
Why?
Carcinoma, Transitional Cell
1
2005
53
0.130
Why?
Neoplasm Proteins
1
2006
190
0.130
Why?
Tumor Markers, Biological
1
2006
240
0.120
Why?
Selective Estrogen Receptor Modulators
1
2004
9
0.120
Why?
Molecular Sequence Data
2
2006
2046
0.120
Why?
CD8-Positive T-Lymphocytes
1
2006
229
0.120
Why?
Cytotoxicity, Immunologic
2
1993
119
0.120
Why?
Mice
6
1987
6206
0.120
Why?
Lymphocytes, Tumor-Infiltrating
1
2004
50
0.120
Why?
Hot Flashes
1
2004
25
0.120
Why?
Acetates
1
2004
65
0.120
Why?
Cell Line, Tumor
1
2006
576
0.120
Why?
Cyclohexanecarboxylic Acids
1
2004
46
0.120
Why?
Tamoxifen
1
2004
84
0.120
Why?
Amines
1
2004
63
0.110
Why?
Neoplasm Metastasis
2
1986
229
0.110
Why?
Angiogenesis Inducing Agents
1
2003
13
0.110
Why?
gamma-Aminobutyric Acid
1
2004
97
0.110
Why?
Enzyme Inhibitors
1
2005
441
0.110
Why?
Dendritic Cells
1
2004
117
0.110
Why?
Adenoviridae
1
2003
130
0.110
Why?
Colorectal Neoplasms
1
2004
143
0.110
Why?
Macrophages
1
2004
347
0.100
Why?
Genes, Lethal
1
2001
12
0.100
Why?
Melanoma
1
2003
132
0.100
Why?
Immunoglobulins
1
1981
77
0.100
Why?
Interferon-gamma
1
2003
341
0.100
Why?
Multiple Myeloma
1
1981
75
0.100
Why?
Multivariate Analysis
1
2003
548
0.100
Why?
Cell Division
2
1991
773
0.090
Why?
Herpesvirus 4, Human
1
2000
66
0.090
Why?
Animals
7
1987
16416
0.090
Why?
Intestine, Small
1
2000
111
0.090
Why?
Chemotherapy, Adjuvant
2
2008
88
0.090
Why?
Antibodies, Monoclonal, Murine-Derived
1
2000
132
0.090
Why?
Lymphoma, Large B-Cell, Diffuse
1
2000
80
0.090
Why?
Antineoplastic Agents
1
2005
628
0.090
Why?
Cancer Vaccines
1
1999
32
0.090
Why?
Time Factors
3
1983
3234
0.080
Why?
Recombinant Proteins
1
2001
770
0.080
Why?
Rectal Neoplasms
1
1999
84
0.080
Why?
Treatment Outcome
4
1999
2671
0.080
Why?
Interleukin-1
1
1999
221
0.080
Why?
Skin Tests
3
1987
34
0.080
Why?
Liver Transplantation
1
2000
244
0.080
Why?
Medical Oncology
1
1997
49
0.080
Why?
Fellowships and Scholarships
1
1997
53
0.070
Why?
Cyclophosphamide
2
1986
177
0.070
Why?
Geriatrics
1
1997
78
0.070
Why?
Adenocarcinoma
2
1992
483
0.070
Why?
Antibodies, Monoclonal
1
2000
748
0.070
Why?
Postoperative Complications
1
2000
764
0.070
Why?
Plasmacytoma
1
1994
10
0.070
Why?
Mice, Inbred DBA
1
1994
92
0.060
Why?
Infant
1
2000
2320
0.060
Why?
HLA-A2 Antigen
1
1993
11
0.060
Why?
Histocompatibility Antigens Class I
1
1994
93
0.060
Why?
Gene Products, gag
1
1993
23
0.060
Why?
Administration, Oral
2
2004
314
0.060
Why?
DNA, Complementary
2
2001
264
0.060
Why?
RNA, Messenger
1
2000
1893
0.060
Why?
Histocompatibility Antigens Class II
1
1994
190
0.060
Why?
Amputation
1
1992
24
0.050
Why?
Genetic Association Studies
1
2012
17
0.050
Why?
tRNA Methyltransferases
1
2012
19
0.050
Why?
Immunohistochemistry
2
2004
1082
0.050
Why?
Treatment Failure
1
2012
131
0.050
Why?
Fingers
1
1992
71
0.050
Why?
Histiocytoma, Malignant Fibrous
1
2011
5
0.050
Why?
Child
1
2000
4342
0.050
Why?
Ferric Compounds
1
1991
25
0.050
Why?
Sarcoma, Synovial
1
2011
7
0.050
Why?
Leiomyosarcoma
1
2011
18
0.050
Why?
Immunosuppression
1
1991
68
0.050
Why?
Liver Neoplasms
1
1992
155
0.050
Why?
Chlorides
1
1991
131
0.050
Why?
Radiotherapy Dosage
1
2011
202
0.050
Why?
Genetic Vectors
2
2001
349
0.050
Why?
Prospective Studies
2
2004
1696
0.050
Why?
Predictive Value of Tests
1
2012
609
0.040
Why?
Survivors
1
2011
118
0.040
Why?
Radiation Injuries
1
2011
131
0.040
Why?
Abdominal Neoplasms
1
2008
17
0.040
Why?
Biopsy, Fine-Needle
1
2008
20
0.040
Why?
Carcinoid Tumor
1
2008
27
0.040
Why?
Adenoma
1
2008
56
0.040
Why?
Pituitary Neoplasms
1
2008
66
0.040
Why?
Radiotherapy, Adjuvant
1
2008
74
0.040
Why?
Cohort Studies
1
2011
984
0.040
Why?
Diphenhydramine
1
1987
7
0.040
Why?
Antigens
1
1987
102
0.040
Why?
Transplantation, Homologous
1
2008
280
0.040
Why?
Hybrid Cells
1
1987
26
0.040
Why?
Immunization, Passive
1
1987
65
0.040
Why?
Skin
1
1990
384
0.040
Why?
Antigens, Surface
1
1987
100
0.040
Why?
Cells, Cultured
1
1993
2589
0.040
Why?
Immunotherapy
1
1986
88
0.040
Why?
Spleen
1
1987
343
0.030
Why?
Receptor, erbB-2
1
2006
66
0.030
Why?
Young Adult
1
2011
1084
0.030
Why?
Chronic Disease
1
2008
554
0.030
Why?
Urothelium
1
2005
20
0.030
Why?
Exanthema
1
2005
12
0.030
Why?
Diarrhea
1
2005
65
0.030
Why?
Intracellular Signaling Peptides and Proteins
1
2006
141
0.030
Why?
Remission Induction
1
2005
165
0.030
Why?
Neutropenia
1
2005
70
0.030
Why?
Microsatellite Repeats
1
2004
41
0.030
Why?
Eosinophils
1
2004
46
0.030
Why?
Arabinofuranosyluracil
1
1983
2
0.030
Why?
Mast Cells
1
2004
48
0.030
Why?
Risk Assessment
1
2008
875
0.030
Why?
Cytarabine
1
1983
93
0.030
Why?
Uridine
1
1983
37
0.030
Why?
Tomography, X-Ray Computed
1
2008
785
0.030
Why?
Injections, Intralesional
1
2003
14
0.030
Why?
beta 2-Microglobulin
1
2003
19
0.030
Why?
Killer Cells, Natural
1
2004
124
0.030
Why?
Leukemia
1
1983
158
0.030
Why?
Pilot Projects
1
2004
446
0.030
Why?
Survival Analysis
1
2004
589
0.030
Why?
Risk Factors
1
2008
2331
0.020
Why?
Ribosomal Proteins
1
2001
38
0.020
Why?
Vaccinia virus
1
2001
56
0.020
Why?
Adolescent
1
2011
5044
0.020
Why?
Interleukin-6
1
2003
339
0.020
Why?
Neoplasms
1
1987
743
0.020
Why?
Follow-Up Studies
1
2005
1889
0.020
Why?
Hepatitis B Antibodies
1
1999
11
0.020
Why?
Lipid A
1
1999
10
0.020
Why?
Mycobacterium
1
1999
8
0.020
Why?
Severity of Illness Index
1
2004
943
0.020
Why?
Adjuvants, Immunologic
1
1999
118
0.020
Why?
Base Sequence
1
2001
1721
0.020
Why?
Gene Expression Regulation
1
2001
895
0.020
Why?
Cell Fusion
1
1987
24
0.010
Why?
DNA, Neoplasm
1
1987
129
0.010
Why?
HeLa Cells
1
1987
299
0.010
Why?
Vaccination
1
1987
254
0.010
Why?
Flow Cytometry
1
1987
603
0.010
Why?
Radioimmunoassay
1
1983
114
0.010
Why?
Infusions, Parenteral
1
1983
72
0.010
Why?
Nucleoside Deaminases
1
1983
21
0.010
Why?
Chromatography, High Pressure Liquid
1
1983
209
0.010
Why?
Dose-Response Relationship, Drug
1
1983
1142
0.010
Why?
Kinetics
1
1983
1471
0.010
Why?
Models, Biological
1
1983
1029
0.010
Why?

Visualizations


Sahasrabudhe's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department